Browse Studies — Arctuva

Phase 1

A Phase 1/2 Study of REGN22530 in Participants With Primary Open Angle Glaucoma or Ocular Hypertension

This study will test an experimental drug called REGN22530 ("study drug") to see if it can help treat people with primary open angle glaucoma or ocular hyperte…

Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07675824

Phase 3

A Comparative Randomized, Investigator-Blind, Active-Controlled, Parallel-Group, Multicenter, Clinical Endpoint Study to Evaluate Efficacy and Safety of Bimatoprost Ophthalmic Solution 0.01% (YSBP) of YS Life Science Co., Ltd. (YSLS) and Lumigan® (Bimatoprost Ophthalmic Solution) 0.01% of AbbVie INC, in the Treatment of Subjects With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH).

This study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. comp…

Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OH)

Estimated

~$10 – $8,750

YS Life Science Co., Ltd.NCT07661329

Phase 2

NADIR Trial: A Principal Investigator-Initiated, Single-Center, Open-Label, Active-Controlled Phase 2a Study of High-Dose Nicotinamide (Vitamin B3) Supplementation in Adults With Mild to Moderate Primary Open-Angle Glaucoma (POAG)

The goal of this clinical trial is to learn whether a high-dose vitamin B3 supplement called nicotinamide can protect retinal nerve cells in adults with primar…

Glaucoma, Open-anglePrimary Open Angle Glaucoma (POAG)

Estimated

~$10 – $6,250

University of ChicagoNCT07808333

Observational

Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries

The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less…

Open Angle Glaucoma (OAG)Primary Open Angle Glaucoma (POAG)Secondary Open Angle Glaucoma

Estimated

~$10 – $6,250

Henry Ford Health SystemNCT07418853

Observational

Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients

The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian pa…

Primary Open Angle Glaucoma (POAG)

Estimated

~$10 – $7,500

Select Eye CareNCT07147647